Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06324357
Title Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | BEL

Facility Status City State Zip Country Details
Valkyrie Clinical Trials RECRUITING Los Angeles California 90067 United States Details
UZ Leuven RECRUITING Leuven 3000 Belgium Details
Fudan University Shanghai Cancer Center RECRUITING Shanghai 200032 China Details
Istituto Europeo di Oncologia RECRUITING Milano 20141 Italy Details
National Cancer Center Hospital East RECRUITING Kashiwa-shi 277-8577 Japan Details
Japanese Foundation for Cancer Research RECRUITING Tokyo, Koto-ku 135-8550 Japan Details
Fundación Jiménez Díaz RECRUITING Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field